111 related articles for article (PubMed ID: 10912783)
1. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
Dobra K; Andäng M; Syrokou A; Karamanos NK; Hjerpe A
Exp Cell Res; 2000 Jul; 258(1):12-22. PubMed ID: 10912783
[TBL] [Abstract][Full Text] [Related]
2. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells.
Gulyás M; Dobra K; Hjerpe A
Differentiation; 1999 Oct; 65(2):89-96. PubMed ID: 10550542
[TBL] [Abstract][Full Text] [Related]
3. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
Gulyás M; Hjerpe A
J Pathol; 2003 Apr; 199(4):479-87. PubMed ID: 12635139
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and expression of mRNA encoding for different versican splice variants is related to the aggregation of human epithelial mesothelioma cells.
Syrokou A; Dobra K; Tzanakakis GN; Hjerpe A; Karamanos NK
Anticancer Res; 2002; 22(6C):4157-62. PubMed ID: 12553048
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
[TBL] [Abstract][Full Text] [Related]
7. Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes.
Makatsori E; Lamari FN; Theocharis AD; Anagnostides S; Hjerpe A; Tsegenidis T; Karamanos NK
Anticancer Res; 2003; 23(4):3303-9. PubMed ID: 12926067
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.
Evanko SP; Johnson PY; Braun KR; Underhill CB; Dudhia J; Wight TN
Arch Biochem Biophys; 2001 Oct; 394(1):29-38. PubMed ID: 11566024
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
10. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells.
Sun X; Dobra K; Björnstedt M; Hjerpe A
Differentiation; 2000 Dec; 66(4-5):181-8. PubMed ID: 11269944
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.
Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E
Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604
[TBL] [Abstract][Full Text] [Related]
13. Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3.
Zhang Y; Wu Y; Cao L; Lee V; Chen L; Lin Z; Kiani C; Adams ME; Yang BB
Exp Cell Res; 2001 Feb; 263(1):33-42. PubMed ID: 11161703
[TBL] [Abstract][Full Text] [Related]
14. Expression of proteoglycans and glycosaminoglycans in angiofibroma and fibrous plaque skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Pesintzaki C; Minas A; Karakiulakis G
Arch Dermatol Res; 2003 Aug; 295(4):138-45. PubMed ID: 12844226
[TBL] [Abstract][Full Text] [Related]
15. Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor.
Tan EM; Hoffren J; Rouda S; Greenbaum S; Fox JW; Moore JH; Dodge GR
Exp Cell Res; 1993 Dec; 209(2):200-7. PubMed ID: 8262136
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma--a connective tissue tumor with proteoglycan-dependent differentiation.
Hjerpe A; Dobra K
Connect Tissue Res; 2008; 49(3):249-51. PubMed ID: 18661353
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy.
Corps AN; Robinson AH; Movin T; Costa ML; Hazleman BL; Riley GP
Rheumatology (Oxford); 2006 Mar; 45(3):291-4. PubMed ID: 16219640
[TBL] [Abstract][Full Text] [Related]
19. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]